Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed in Geriatric Individuals
25 april 2026 bijgewerkt door: Gulfidan Tokgoz, Istanbul University - Cerrahpasa
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over.
The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8
m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Studie Overzicht
Toestand
Nog niet aan het werven
Interventie / Behandeling
Gedetailleerde beschrijving
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed.
This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
Studietype
Observationeel
Inschrijving (Geschat)
76
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Telefoonnummer: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
Studie Locaties
-
-
-
Balıkesir, Turkije (Türkiye)
- Balıkesir University
-
Contact:
- GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Telefoonnummer: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
-
Onderonderzoeker:
- Bilal Katipoğlu, Assoc. Prof. Dr.
-
Contact:
- Nilay ARMAN, Assoc. Prof. Dr.
- Telefoonnummer: +905534558707
-
Onderonderzoeker:
- Saime Nilay Arman, Assoc. Prof. Dr.
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Bemonsteringsmethode
Kanssteekproef
Studie Bevolking
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
Beschrijving
Inclusion Criteria:
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Exclusion Criteria:
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
- Individuals experiencing significant difficulty communicating
- Participants who did not sign the voluntary consent form
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Geriartric Indivıduals
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
|
Assessments will be conducted after obtaining voluntary consent from the participants.
The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
4-Meter Walk Test (Walking Speed Measurement)
Tijdsspanne: 1 week
|
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals.
Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course.
The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
|
1 week
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Time Sit-Stand Test (5STS):
Tijdsspanne: 1 week
|
To assess lower extremity muscle strength and balance, participants will be asked to stand up and sit down as quickly as possible, five times consecutively, from a standard chair 43-45 cm high, with their arms crossed over their chest.
The timer will start with the "start" command and end when the fifth sitting is completed (Bohannon, 2006).
|
1 week
|
|
Timed Up and Go (TUG):
Tijdsspanne: 1 week
|
To measure functional mobility, the participant will get up from the chair, walk a distance of 3 meters, return, and sit back down in the chair.
This time will be recorded in seconds using a stopwatch (Podsiadlo & Richardson, 1991).
|
1 week
|
|
Functional Reach Test (FUT/FRT)
Tijdsspanne: 1 week
|
To measure static balance and stability limits, the maximum distance the participant can reach without losing balance and without taking a step, while standing next to a wall with the shoulder flexed at 90 degrees, will be measured (Duncan et al., 1990).
|
1 week
|
|
Single Leg Balance Test (Right and Left):
Tijdsspanne: 1 week
|
Participants' static balance will be determined by recording the "time they can stand on one leg" (maximum 60 seconds) with their eyes open and hands on their hips, on both their dominant and non-dominant legs (Springer et al., 2007).
|
1 week
|
|
Flexibility (Sit-and-Reach Test):
Tijdsspanne: 1 week
|
To measure hamstring and lower back flexibility, the participant will sit in a long, straight position, reaching forward without bending their knees.
The distance reached by their fingertips will be recorded on a "sit-and-reach bench" (Wells & Dillon, 1952).
|
1 week
|
|
Stair Climbing Test
Tijdsspanne: 1 week
|
To assess high-level mobility, participants will be recorded in seconds for safely and as quickly as possible ascending and descending a staircase of standard step height [a specified number of steps, e.g., 10 steps] (Nightingale et al., 2003).
|
1 week
|
|
Strength Measurement (Hand Grip Strength):
Tijdsspanne: 1 week
|
Upper extremity muscle strength will be measured using a digital hand dynamometer according to the ASHT (American Society of Hand Therapists) protocol.
Participants will be asked to grip with maximum force while sitting upright, with shoulder adduction and elbow 90 degrees flexed.
Three repetitions will be performed for each hand, and the average of these measurements in kilograms (kg) will be included in the analysis (Roberts et al., 2011; Cruz-Jentoft et al., 2019).
|
1 week
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Algemene publicaties
- Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
- Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
1 mei 2026
Primaire voltooiing (Geschat)
15 mei 2026
Studie voltooiing (Geschat)
30 augustus 2026
Studieregistratiedata
Eerst ingediend
25 april 2026
Eerst ingediend dat voldeed aan de QC-criteria
25 april 2026
Eerst geplaatst (Werkelijk)
1 mei 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
1 mei 2026
Laatste update ingediend die voldeed aan QC-criteria
25 april 2026
Laatst geverifieerd
1 april 2026
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 2026/46
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .